Braidwell’s Xenon Pharmaceuticals XENE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$77.8M Sell
1,338,452
-486,624
-27% -$22.4M 2.6% 8
2025
Q4
$81.8M Sell
1,825,076
-1,779,953
-49% -$74.8M 2.62% 9
2025
Q3
$145M Hold
3,605,029
4.29% 4
2025
Q2
$113M Buy
3,605,029
+895,154
+33% +$29.2M 3.86% 5
2025
Q1
$90.9M Sell
2,709,875
-204,089
-7% -$7.75M 3.2% 7
2024
Q4
$114M Buy
2,913,964
+206,709
+8% +$8.55M 3.39% 6
2024
Q3
$107M Buy
2,707,255
+146,682
+6% +$5.91M 3.02% 6
2024
Q2
$99.8M Buy
2,560,573
+1,252,562
+96% +$50.1M 3.13% 7
2024
Q1
$56.3M Sell
1,308,011
-339,300
-21% -$15.6M 1.81% 19
2023
Q4
$75.9M Sell
1,647,311
-456,085
-22% -$16.1M 2.79% 8
2023
Q3
$71.9M Buy
2,103,396
+275,043
+15% +$10.3M 2.27% 10
2023
Q2
$70.4M Sell
1,828,353
-308,757
-14% -$12.3M 2.3% 13
2023
Q1
$76.5M Buy
2,137,110
+589,000
+38% +$21.8M 2.52% 11
2022
Q4
$61M Buy
+1,548,110
New +$56.4M 2.05% 14

Other funds holding XENE